Skip to Main Content
Skip Nav Destination

Issues

Neuroimmunomodulation 2015, Vol. 22, No. 1-2

 

Neuroimmunomodulation (2014) 22 (1-2): 1–2. https://doi.org/10.1159/000364838

Introduction

Neuroimmunomodulation (2014) 22 (1-2): 3–5. https://doi.org/10.1159/000362737

Basic Research concerning Glucocorticoids

Neuroimmunomodulation (2014) 22 (1-2): 6–19. https://doi.org/10.1159/000362736
Neuroimmunomodulation (2014) 22 (1-2): 20–32. https://doi.org/10.1159/000362724
Neuroimmunomodulation (2014) 22 (1-2): 33–39. https://doi.org/10.1159/000362733
Neuroimmunomodulation (2014) 22 (1-2): 40–45. https://doi.org/10.1159/000362725

Efficacy of Low-Dose Glucocorticoids in Clinical Trials

Neuroimmunomodulation (2014) 22 (1-2): 46–50. https://doi.org/10.1159/000362734
Neuroimmunomodulation (2014) 22 (1-2): 51–56. https://doi.org/10.1159/000362728

Safety of Low-Dose Glucocorticoids in Rheumatoid Arthritis

Neuroimmunomodulation (2014) 22 (1-2): 57–65. https://doi.org/10.1159/000362726
Neuroimmunomodulation (2014) 22 (1-2): 66–71. https://doi.org/10.1159/000362729
Neuroimmunomodulation (2014) 22 (1-2): 72–82. https://doi.org/10.1159/000362727
Neuroimmunomodulation (2014) 22 (1-2): 83–88. https://doi.org/10.1159/000362731

Observational Studies and Clinical Experience with Low-Dose Glucocorticoids

Neuroimmunomodulation (2014) 22 (1-2): 89–103. https://doi.org/10.1159/000362735
Neuroimmunomodulation (2014) 22 (1-2): 104–111. https://doi.org/10.1159/000362730
Neuroimmunomodulation (2014) 22 (1-2): 112–118. https://doi.org/10.1159/000362732

 

Neuroimmunomodulation (2014) 22 (1-2): 119. https://doi.org/10.1159/000364839
Neuroimmunomodulation (2014) 22 (1-2): 120. https://doi.org/10.1159/000364840
Close Modal

or Create an Account

Close Modal
Close Modal